$TBBK

Egan Martin sold $220K of TBBK

Egan Martin (Chief Accounting Officer) sold 3,057 shares of Bancorp, Inc. (TBBK) at an average of $72.03 ($72.01–$72.07, $0.22M total) across 2 trades on 2026-08-06.

Original reporting
SEC EDGAR · Egan Martin
Published Aug 6, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 7:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TBBK
Neutral
medium confidence
Mentioned
$TBBK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TBBKNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (shares, price range, total value, and post-transaction holdings).

02

Market read

Traders may monitor insider activity for sentiment, but this filing alone does not change the company’s fundamentals.

03

What to watch

Insider sales are often driven by diversification, taxes, or personal liquidity needs; the article provides no rationale or follow-on buying.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-06, same day as the sale

Background

The article is an SEC Form 4 insider transaction disclosure for Bancorp, Inc. (TBBK).

Company-level read

Ticker impact

$TBBKNeutralMedium confidence
Context

Bancorp, Inc. Form 4 shows CFO Egan Martin sold 3,057 shares on 2026-08-06 at about $72.03, totaling ~$220k.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a primary insider transaction disclosure, but it does not include new company fundamentals, guidance, or regulatory/operational developments.

Market effects

Minimal, as the disclosure is company-specific insider selling without sector-wide signal.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted by some traders as less “scheduled,” potentially increasing short-term scrutiny.

Key entities

  • Bancorp, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Egan Martin

    Chief Accounting Officer who sold shares on 2026-08-06.

Related articles

$TBBKMedAI 8/10

Bancorp (TBBK) Q2 2026 Earnings Call Transcript

Bancorp (TBBK) discussed its Q2 2026 earnings call, citing fintech GDV growth of 22.5% YoY and fintech revenue growth of 21% YoY. The company raised full-year 2026 EPS guidance to $5.95 to $6.05, with Q4 2026 EPS guidance of $1.65 to $1.75 and 2027 EPS guidance of $8.10 to $8.30. It forecast $200M buybacks in 2026.

$TBBKMed

Why The Bancorp Stock Popped Again Today

The Bancorp (TBBK) shares rose nearly 7% on Monday after two analysts raised price targets following its Q2 earnings. Piper Sandler’s Manuel Navas lifted fair value to $86 from $70 and kept an overweight rating, citing guidance for double-digit EPS growth and ongoing share repurchases. Keefe, Bruyette & Woods raised its target to $79 from $77 and kept a buy-equivalent rating.

$TBBKMed

Why The Bancorp Stock Beat the Market on Friday

The Bancorp (TBBK) rose about 3.5% on Friday after its Q2 results showed a bottom-line beat and raised full-year GAAP earnings guidance. Revenue was $163.5M vs $166.7M expected. GAAP net income was under $60.7M, about $1.45/share. Full-year guidance increased to $5.95-$6.05/share.

$TBBKMed

Bancorp, Inc. (TBBK): Results of Operations and Financial Condition

Bancorp, Inc. (TBBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tbbk-20260730xexx991.htm EX-99.1 Document Exhibit 99.1 THE BANCORP REPORTS 2Q 2026 EPS OF $1.45, ROA OF 2.51%, AND ROE OF 34.7% DRIVEN BY STRONG GROWTH IN LOANS AND FINTECH FEES; CONTINUED IMPROVEMENT IN CREDIT AND COST EFFICIENCIES Second Quarter 2026 Highlights • Earn

$TBBKMed

Why The Bancorp Stock Surged Today

The Bancorp (NASDAQ: TBBK) shares rose nearly 8% on Thursday after Keefe, Bruyette & Woods upgraded the stock. Analyst Timothy Switzer raised his rating to “outperform” from “market perform,” citing The Bancorp’s shift toward third-party banking services and expectations it can meet management’s guidance, with potential for higher growth versus traditional peers.